Skip to main content

January 2013

academics

 

Clinical research courses

Opportunity for Clinical Safety Scientist in Novartis

BITS Pilani invites Professor, Associate Professor, Assistant Professor, Lecturer

The Birla Institute of Technology & Science, BITS Pilani is an all-India Institute for higher education. The primary motive of BITS is to "train young men and women able and eager to create and put into action such ideas, methods, techniques and information". The Institute is a dream come true of its founder late Mr G.D.Birla - an eminent industrialist, a participant in Indian freedom struggle and a close associate of the Father of Indian Nation late Mr. Mohandas Karamchand Gandhi (Mahatma Gandhi).

Walk in interview for Research Assistant in National Institute of Occupational Health

This Institute started as “Occupational Health Research Institute” (OHRI) in the year 1966 and was re-christened as “National Institute of Occupational Health” (NIOH) in 1970 presently located in the Eastern part of Ahmedabad. Two Regional Occupational Health Centers (ROHCs) were started at Bangalore in 1977 and at Kolkata in 1980.

Post: Research Assistant (One)

Work as Senior Research Fellow in Indian Agricultural Research Institute | Walk in

INDIAN DRUG REGULATORY SYSTEM: MOVING TO A NEW ERA

About Author:
Priyank Sharma
M. Pharm, Drug Regulatory Affairs
Jaipur National University
Jaipur, Rajasthan
Priyank2k4urwith@gmail.com

Abstract:
The Pharmaceutical industry represents one of the India’s strength.  The regulation of pharmaceuticals in India is generally seen to be in need of reform, and has been the subject of many official commissions since 1995. Most commentators agree that the state should intervene to prevent untrammeled market forces leading to citizens’ suffering, because adequate information about the costs and benefits of different pharmaceuticals is inaccessible to most users. But in India, a wide range of stakeholders must be considered before changes can be made to the regulatory framework.

A REVIEW ON MUSSAENDA SPECIES

About Authors:
Bharathi.V*, SwarnaLatha.D, M.Sreenivasulu

Annamcharya college of pharmacy, newboyana pally, rajampet(M),
kadapa(dt). Andhara Pradesh, India.
*bharu.v.net@gmail.com

ABSTRACT:
Medicinal plants have played an essential role in the development of human culture. Many of the modern medicines are produced indirectly from medicinal plants, for example aspirin. The present study was concentrated on past work reported on the some mussaenda species and study of different activities and phyto constitutions reported on mussaenda species. The genus Mussaenda (rubiaceae) is an important source of medicinal natural products, steroids, flavonoids, glycosides and only a few number of species reported positive for alkaloids and tannins. Many Mussaenda species were reported to possess anti-oxidant, anti-inflammatory in different models, analgesic, antimicrobial, diuretic, antiphlogistic and antipyretic, acute gastroenteritis and dysentery, anti- fertility activity, antiviral property , antibacterial effect rarely for hepato protective activity and wound healing activity.

Application are invited for the Post of Junior Research Fellow in Delhi Technological University

Till 1962, the college was under the direct control of Ministry of Education, Government of India. In 1963, the administration of the college was handed over to Delhi Administration. Delhi College of Engineering was under the administrative control of Department of Technical Education & Training, Govt. of NCT of Delhi. For academic purposes, the college was affiliated to University of Delhi since 1952. From July 2009, the DCE has become Delhi Technological University vide Delhi act 6 of 2009.

Clinical Development Services Agency Require M.Pharm/M.Sc/MBBS for post of SENIOR RESEARCH OFFICER and RESEARCH OFFICER

Clinical Development Services Agency (CDSA) is an extramural unit of THSTI and has been established as a not-for-profit society to provide cost effective, high quality preclinical and clinical product development support services to meet the country's growing healthcare needs. It will tend enterprises - particularly SMEs involved in new technology innovation and facilitate translation of scientific know-how into viable products.

FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLETS FROM SOLID DISPERSIONS OF LOVASTATIN

About Authors:
Khayyam Shaikh*, Patwekar Shailesh, Santosh Payghan, John Disouza
Department of Pharmaceutics,
Tatyasaheb Kore College of Pharmacy,
Warananagar, Kolhapur, Maharashtra, India 416113.
*ramzanshek0587@gmail.com

ABSTRACT
During the last two decades there has been a remarkable increase in interest in sustained release drug delivery system. This has been due to various factors viz. the extensive cost of developing new drug entities, expiration of existing international patents, discovery of new polymeric materials suitable for prolonging the drug release, and improvement in therapeutic efficacy and safety achieved by this delivery system. A number of design options are available for the preparation of controlled release formulations to modify oral absorption. Formulation approaches are being explored to enhance bioavailability of poorly water-soluble drugs. One such approach that has been shown significantly enhanced absorption of such drugs is to formulate solid dispersionand then formulate its tablets. Solid dispersion technology can be used to improve the in- vitro and in- vivo dissolution properties of slightly water soluble drugs and to control their dissolution rate. In this current study attempts have been made to formulate sustained release tablets of solid dispersions.